세계의 방사선 피부염 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 2024년부터 2032년까지의 예측
Global Radiation Dermatitis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
상품코드:1547519
리서치사:Value Market Research
발행일:2024년 07월
페이지 정보:영문 128 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
방사선 피부염 시장의 세계 수요는 2024-2032년간 5.55%의 연평균 복합 성장률(CAGR)로 2023년 5억 241만 달러에서 2032년에는 약 8억 1,693만 달러에 달할 것으로 추정됩니다.
방사선 피부염 또는 방사선 피부염은 암 종양에 대한 방사선 치료의 외부 빔 이온화 방사선으로 인한 피부 손상 또는 방사선 화상입니다. 또한 색전술, 관상 동맥 조영술, 카테터 삽입과 같은 중재 적 시술 중 방사선 노출로 인해 드물게 발생할 수 있습니다. 방사선 피부염은 주로 부신피질 스테로이드, 국소 항생제, 친수성 크림과 같은 외용제, 경구용 부신피질 스테로이드, 경구용 진통제, 항염증제, 항생제, 드레싱 재료와 같은 경구용 약물로 치료합니다.
시장 역학
방사선 치료, 색전술, 관상동맥 조영술, 카테터 삽입 등의 시술 건수 증가가 방사선 피부염 유병률 증가의 원인으로 작용하고 있습니다. 암 부담 증가와 강도조절 방사선 치료와 같은 방사선 조사 기술의 발전이 세계 방사선 피부염 시장을 주도하고 있습니다. 방사선 치료는 방사선 피부염 증가에 크게 기여하고 있습니다. 방사선 치료는 여전히 암 치료에 필수적인 요소로, 암 환자의 약 50%가 치료 중 방사선 치료를 받고 있습니다. 방사선 치료와 관련된 부작용을 줄이기 위한 노력이 증가함에 따라 예측 기간 동안 시장 확대에 유리한 기회를 제공할 것으로 예상됩니다. 그러나 방사선 피부염 치료에 대한 인식 부족과 높은 비용이 시장 성장을 제한할 것으로 예상됩니다.
조사 보고서는 Porter's Five Forces 모델, 시장 매력도 분석, 밸류체인 분석을 다루고 있습니다. 이러한 도구는 산업 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이 됩니다. 또한 이러한 도구는 세계의 방사선 피부염 시장에서 각 부문을 종합적으로 평가할 수 있습니다. 방사선 피부염 산업의 성장과 동향은 이 조사에 대한 전체적인 접근 방식을 설명합니다.
시장 세분화
방사선 피부염 시장 세분화는 국가 및 지역별 부문에 대한 상세한 데이터를 제공하여 전략 담당자가 각 제품 및 서비스의 대상 고객을 식별하는 데 도움이 되는 정보를 제공합니다.
지역 분석
이 섹션에서는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카의 방사선 피부염 시장의 현재와 미래 수요를 강조하는 지역 전망을 다룹니다. 또한, 모든 주요 지역의 개별 응용 분야에 대한 수요, 추정 및 예측에 초점을 맞추었습니다.
맞춤형 요구사항이 있는 경우, 저희에게 연락주시기 바랍니다. 당사의 조사팀은 고객의 요구에 따라 맞춤형 보고서를 제공할 수 있습니다.
The global demand for Radiation Dermatitis Market is presumed to reach the market size of nearly USD 816.93 Million by 2032 from USD 502.41 Million in 2023 with a CAGR of 5.55% under the study period 2024-2032.
Radiation dermatitis, radiodermatitis, or x-ray dermatitis is skin damage or a radiation burn caused by external beam ionizing radiation of radiotherapy for cancer tumors. It may also rarely result from exposure to radiation during interventional procedures such as embolization procedures, coronary angiography, and indwelling catheter placements. Radiation dermatitis is primarily treated with topical agents such as corticosteroids, topical antibiotics, hydrophilic creams, oral medications like oral corticosteroids, oral analgesics, anti-inflammatory agents, antibiotics, and dressings.
MARKET DYNAMICS
A rising number of procedures, including radiotherapy, embolization procedures, coronary angiography, and indwelling catheter placements, are responsible for increasing radiation dermatitis prevalence. The escalating burden of cancer and advances in radiation delivery technology, such as intensity-modulated radiation therapy, is driving the global radiation dermatitis market. Radiotherapy is majorly contributing to the rising radiation dermatitis incidences. Radiation therapy remains an essential component of cancer treatment, with nearly 50% of cancer patients receiving radiation therapy at some point during their treatment. Rising effort towards reducing side effects associated with radiation therapy is expected to offer lucrative opportunities for the market expansion during the forecast timeframe. However, lack of awareness and the high cost associated with radio dermatitis treatment is anticipated to restrict the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Radiation Dermatitis. The growth and trends of Radiation Dermatitis industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Radiation Dermatitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Radiation Dermatitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiation Dermatitis market include 3M Company, MeInlycke Health Care AB, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, Intermed S.A, ConvaTec Group Plc, BMG Pharma S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.2 Market Attractiveness Analysis By Distribution Channel
3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Historic and Forecast Sales By Regions
5.4. Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Historic and Forecast Sales By Regions
5.5. Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Historic and Forecast Sales By Regions
6. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
6.4. Retail Pharmacies Historic and Forecast Sales By Regions
6.5. Online Pharmacies Historic and Forecast Sales By Regions
6.6. Retail Pharmacies Historic and Forecast Sales By Regions
7. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY GEOGRAPHY
7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
7.3.1 Overview, Historic and Forecast Data Sales Analysis
7.3.2 North America By Segment Sales Analysis
7.3.3 North America By Country Sales Analysis
7.3.4 United States Sales Analysis
7.3.5 Canada Sales Analysis
7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
7.4.1 Overview, Historic and Forecast Data Sales Analysis
7.4.2 Europe By Segment Sales Analysis
7.4.3 Europe By Country Sales Analysis
7.4.4 United Kingdom Sales Analysis
7.4.5 France Sales Analysis
7.4.6 Germany Sales Analysis
7.4.7 Italy Sales Analysis
7.4.8 Russia Sales Analysis
7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
7.5.1 Overview, Historic and Forecast Data Sales Analysis
7.5.2 Asia Pacific By Segment Sales Analysis
7.5.3 Asia Pacific By Country Sales Analysis
7.5.4 China Sales Analysis
7.5.5 India Sales Analysis
7.5.6 Japan Sales Analysis
7.5.7 South Korea Sales Analysis
7.5.8 Australia Sales Analysis
7.5.9 South East Asia Sales Analysis
7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
7.6.1 Overview, Historic and Forecast Data Sales Analysis
7.6.2 Latin America By Segment Sales Analysis
7.6.3 Latin America By Country Sales Analysis
7.6.4 Brazil Sales Analysis
7.6.5 Argentina Sales Analysis
7.6.6 Peru Sales Analysis
7.6.7 Chile Sales Analysis
7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
7.7.1 Overview, Historic and Forecast Data Sales Analysis
7.7.2 Middle East & Africa By Segment Sales Analysis
7.7.3 Middle East & Africa By Country Sales Analysis
7.7.4 Saudi Arabia Sales Analysis
7.7.5 UAE Sales Analysis
7.7.6 Israel Sales Analysis
7.7.7 South Africa Sales Analysis
7.7.8 Rest Of Middle East And Africa Sales Analysis
8. COMPETITIVE LANDSCAPE OF THE RADIATION DERMATITIS COMPANIES
8.1. Radiation Dermatitis Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments
9. COMPANY PROFILES OF RADIATION DERMATITIS INDUSTRY
9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. 3M Company
9.3.1 Company Overview
9.3.2 Company Revenue
9.3.3 Products
9.3.4 Recent Developments
9.4. MeInlycke Health Care AB
9.4.1 Company Overview
9.4.2 Company Revenue
9.4.3 Products
9.4.4 Recent Developments
9.5. Smith & Nephew Plc
9.5.1 Company Overview
9.5.2 Company Revenue
9.5.3 Products
9.5.4 Recent Developments
9.6. Integra Lifesciences Holdings Corporation
9.6.1 Company Overview
9.6.2 Company Revenue
9.6.3 Products
9.6.4 Recent Developments
9.7. Intermed S.A
9.7.1 Company Overview
9.7.2 Company Revenue
9.7.3 Products
9.7.4 Recent Developments
9.8. ConvaTec Group Plc
9.8.1 Company Overview
9.8.2 Company Revenue
9.8.3 Products
9.8.4 Recent Developments
9.9. BMG Pharma S.P.A
9.9.1 Company Overview
9.9.2 Company Revenue
9.9.3 Products
9.9.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
